The US market says otherwise @imback.
Those are serious analysts who are unpacking the data and they've got more money and clout than you.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-502
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
0.280(11.0%) |
Mkt cap ! $3.245B | |||
| Open | High | Low | Value | Volume |
| $2.74 | $2.84 | $2.68 | $48.39M | 17.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 212409 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 9068 | 2 |
View Market Depth
| Last trade - 16.10pm 27/12/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
